offering a detailed and comprehensive perspective on the cost-effectiveness of GA for Relapsing-Remitting Multiple Sclerosis (RRMS) from the standpoint of the UK National Health Service
safety of these drugs was assessed in Mexican patients under treatment for relapsing-remitting multiple sclerosis (RRMS). A parallel, multicenter, prospective and comparative study was carried out. Fifty patients with…
flexibility and body balance among RRMS patients. Methods: Twenty-two subjects affected by relapsing-remitting multiple sclerosis (RRMS, EDSS ≤ 6) were randomly divided into 3 groups whose members each performed
that may serve to assess the risk of cognitive impairment in patients with relapsing remitting multiple sclerosis (RRMS). Methods: A total of 81 RRMS patients (mean age 41.09 ± 8.71 years
Multiple sclerosis (MS) is a chronic autoimmune neurological disease characterized by a demyelinating inflammatory response of the central nervous system (CNS). During the natural evolution of the disease there…
objective was to describe vestibular abnormalities in patients with relapsing and remitting multiple sclerosis. Thirty patients (6 men and 24 women) between 27 and 64 years of age underwent neurological
abnormalities in fractional anisotropy (FA) may be involved in cognitive dysfunctions in Relapsing-Remitting (RR)-Multiple Sclerosis (MS). Objective: The aim of our study was to investigate the microstructural integrity
second line therapy in multiple sclerosis (MS) and optic neuritis (ON) and usually regarded as a therapy option in case of steroidrefractory relapse in most guidelines. However, systematic prospective data ... patients…
Introduction: Quality of life (QoL) has gained increasing importance in multiple sclerosis (MS). We aimed to assess QoL and potentially associated factors such as depression, sexual dysfunction and work absenteeism…
Fingolimod (GilenyaÃ?®, Novartis Pharma AG) is a sphingosine 1-phosphate receptor modulator approved for relapsing MS treatment. Continuous collection and analysis of real world effectiveness and safety data…
patients with Multiple Sclerosis (MS); nevertheless, previous studies reported lower PA rates among these patients as compared to healthy subjects. Our study aims to assess PA in Relapsing-remitting
negative association between human immunodeficiency virus (HIV) Infection and multiple sclerosis (MS) is expected, as MS pathogenesis is triggered by auto-reactive T-cells, which are depressed in case ... benefit from…
assess the socio-economic burden that MS imposes to Greek patients with relapsing forms of multiple sclerosis. Methods: Information on demographics, disease history, resource consumption and productivity losses was…
immunogenic.Objective:In the present study an evaluation of serum anti-MOG antibody in relapsing remitting multiple sclerosis (RRMS)patientswas carried out. Method:Serum levels of anti-MOG were measured…
Among these, the width of the third ventricle might be relevant for patients with multiple sclerosis (MS). To explore its value, we performed an observational study of a cohort ... examinations at study entry. Methods…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.